Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almer M van der Sloot

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|May 14, 2008
DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based designVicente Tur, Almer M van der Sloot, Carlos R Reis, et al.
Chembiochem : a European Journal of Chemical Biology|April 3, 2008
A novel genetic selection system for improved enantioselectivity of Bacillus subtilis lipase AYkelien L Boersma, Melloney J Dröge, Almer M van der Sloot, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2006
Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptorAlmer M van der Sloot, Vicente Tur, Eva Szegezdi, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 12, 2007
RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL)Marc Tarrus, Almer M van der Sloot, Kai Temming, et al.
The Journal of Biological Chemistry|September 11, 2012
The design and characterization of receptor-selective APRIL variantsFiona C Kimberley, Almer M van der Sloot, Marco Guadagnoli, et al.
Biochemistry|February 25, 2009
Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptorsCarlos R Reis, Almer M van der Sloot, Eva Szegezdi, et al.
Journal of Biotechnology|January 14, 2003
Binding of phage displayed Bacillus subtilis lipase A to a phosphonate suicide inhibitorMelloney J Dröge, Carsten J Rüggeberg, Almer M van der Sloot, et al.
Scientific Reports|March 8, 2023
A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assayBeatrice Alexander-Howden, Li Zhang, Almer M van der Sloot, et al.
Nature Methods|September 3, 2013
Engineering of weak helper interactions for high-efficiency FRET probesRaik Grünberg, Julia V Burnier, Tony Ferrar, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2012
Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAILEva Szegezdi, Almer M van der Sloot, Devalingam Mahalingam, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|May 14, 2008
DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based designVicente Tur, Almer M van der Sloot, Carlos R Reis, et al.
Chembiochem : a European Journal of Chemical Biology|April 3, 2008
A novel genetic selection system for improved enantioselectivity of Bacillus subtilis lipase AYkelien L Boersma, Melloney J Dröge, Almer M van der Sloot, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2006
Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptorAlmer M van der Sloot, Vicente Tur, Eva Szegezdi, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 12, 2007
RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL)Marc Tarrus, Almer M van der Sloot, Kai Temming, et al.
The Journal of Biological Chemistry|September 11, 2012
The design and characterization of receptor-selective APRIL variantsFiona C Kimberley, Almer M van der Sloot, Marco Guadagnoli, et al.
Biochemistry|February 25, 2009
Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptorsCarlos R Reis, Almer M van der Sloot, Eva Szegezdi, et al.
Journal of Biotechnology|January 14, 2003
Binding of phage displayed Bacillus subtilis lipase A to a phosphonate suicide inhibitorMelloney J Dröge, Carsten J Rüggeberg, Almer M van der Sloot, et al.
Scientific Reports|March 8, 2023
A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assayBeatrice Alexander-Howden, Li Zhang, Almer M van der Sloot, et al.
Nature Methods|September 3, 2013
Engineering of weak helper interactions for high-efficiency FRET probesRaik Grünberg, Julia V Burnier, Tony Ferrar, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2012
Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAILEva Szegezdi, Almer M van der Sloot, Devalingam Mahalingam, et al.
Pageof 4